---

ANTIOXIDANTS IN PERIODONTICS

Comprehensive Postgraduate Theory Examination Notes

---

SECTION 1: DEFINITIONS AND BASIC CONCEPTS

1.1 Reactive Oxygen Species (ROS) - Definition

• Reactive oxygen species (ROS): "Highly reactive oxygen-based molecules, such as the hydroxyl radical, superoxide, and peroxide." (Newman & Carranza's Clinical Periodontology and Implantology, 14th ed. - eTABLE 8.2 Glossary of Terms Relevant to Periodontal Immunobiology)
• Various nutrients "act to ameliorate the destructive effects of reactive oxygen species (ROS) functioning as ROS scavengers." (Newman & Carranza, 14th ed.)

1.2 Role of ROS in Periodontal Pathogenesis

• Neutrophils "release large quantities of destructive enzymes (e.g., MMPs)... Neutrophils also release their potent lysosomal enzymes, cytokines, and reactive oxygen species (ROS) extracellularly, thereby causing further collagen depletion and tissue damage."
• "Patients with periodontitis have been reported to have neutrophils that demonstrate enhanced enzymatic activity and that produce increased levels of ROS." (Newman & Carranza, 14th ed., Chapter 8 - Periodontal Disease Pathogenesis)
• "The migration of neutrophils contributes to the disruption of the junctional epithelium by the degradation of the basement membrane through protease release and the action of ROS." (Newman & Carranza, 14th ed.)
• "Reactive oxygen species are a major component of the neutrophil response to bacteria." (Newman & Carranza, 14th ed., Chapter 10)

---

SECTION 2: OXIDATIVE STRESS AND PERIODONTAL DISEASE

2.1 Oxidative Stress in Periodontitis

• "There is evidence of higher serum levels of markers of oxidative stress and of decreased antioxidant capacity in individuals with periodontitis when compared to periodontally healthy controls." (Chapple & Matthews 2007, cited in: Clinical Periodontology and Implant Dentistry, 6th ed.)
• "Adipokine action and oxidative stress have been proposed to serve as the common link in the pathobiology of obesity and periodontitis." (Bullon et al. 2009, cited in: Clinical Periodontology and Implant Dentistry, 6th ed.)
• Reference cited in Clinical Periodontology and Implant Dentistry 6th ed.: Chapple, I.L. & Matthews, J.B. (2007). The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontology 2000 43, 160-232.

2.2 Oxidative Stress and Diabetes-Associated Periodontitis

• "Expression of AGE ligands and of markers of oxidative stress was demonstrated in gingival tissues of patients with diabetes and periodontitis." (Schmidt et al. 1996, cited in: Clinical Periodontology and Implant Dentistry, 6th ed.)
• Hyperglycemia leads to: "Enhanced inflammation, production of reactive oxygen species or oxidative stress, and compromised tissue repair. Hyperglycemia also promotes oxidative stress directly, and both inflammation and oxidative stress can contribute to further AGE formation." (Clinical Periodontology and Implant Dentistry, 6th ed.)
• "Advanced glycation end products (AGEs) may arise which lead to the release of free oxygen and pro-inflammatory mediators (cytokines). AGEs may also promote chemotaxis and adhesion of inflammatory cells to periodontal tissues, and increased apoptosis of fibroblasts and osteoblasts may occur." (Newman & Carranza, 14th ed.)

2.3 Flowchart: Oxidative Stress Pathway in Diabetes-Associated Periodontitis

HYPERGLYCEMIA
     |
     v
Advanced Glycation End Products (AGEs)
     |
     v
Receptor for Advanced Glycation End Products (RAGE)
     |
     +---> Cell Stress
     |
     v
INFLAMMATION <----------> OXIDATIVE STRESS
     |                           |
     +--------+------------------+
              |
              v
         Impaired REPAIR
              |
              v
     PERIODONTAL DESTRUCTION
              ^
              |
     Periodontal Bacteria (perpetuate cycle)

2.4 Oxidative Stress and Smoking

• "Due to the consumption of tobacco, reactive oxygen (radicals) is released that chemically irritate periodontal tissues by DNA damage, lipid peroxidation of cell membranes, damage of endothelial cells, and induction of smooth muscle cell growth." (Newman & Carranza, 14th ed.)
• "Generation of free oxygen radicals from neutrophils also is increased in smokers compared with nonsmokers. Levels of metallothionein, a free radical scavenger, are increased in gingival tissues of smokers compared with nonsmokers. This increased defense against free radicals in gingival tissue of smokers suggests that inflammation is much greater in smokers compared with nonsmokers regardless of periodontal status." (Periodontics Medicine Surgery Implants)

2.5 Oxidative Stress and Malnutrition / Necrotizing Periodontal Disease

• "In response to periodontal pathogens, phagocytes elaborate destructive oxidants, proteinases, and other factors. Periodontal damage may occur as the result of the interaction between these factors, the antioxidants, and the host-derived antiproteinases."
• "Malnutrition is characterized by marked tissue depletion of the key antioxidant nutrients and impaired acute-phase protein response to infections. This is due to impairment in the production and cellular action of the cytokines." (Clinical Periodontology and Implant Dentistry, 6th ed., Chapter on Necrotizing Periodontal Diseases)

---

SECTION 3: ANTIOXIDANT MICRONUTRIENTS IN PERIODONTICS

Table 1: Antioxidant Micronutrients - Role and Periodontal Relevance

Table 2: Classification of Micronutrients Associated with Periodontal Status

---

SECTION 4: VITAMIN C (ASCORBIC ACID) - DETAILED ANALYSIS

4.1 Historical Significance

• "The effect of ascorbic acid (vitamin C) deficiency on the gingival tissues has been known since the 18th century, when an association between scurvy and bleeding gums and tooth loss was first observed in sailors who did not have access to fresh fruit and vegetables over prolonged time periods." (Clinical Periodontology and Implant Dentistry, 6th ed.)
• Newman 14th ed. notes: "The one nutritional deficiency that has well-documented effects on periodontal tissue is the reduction of plasma ascorbic acid (vitamin C)."

4.2 Mechanisms of Action of Vitamin C

• "Vitamin C is a powerful antioxidant radical scavenger (Da Costa et al. 2012) that is distributed in many cell types, including polymorphonuclear leukocytes, platelets, and endothelial cells (Evans et al. 1982), and which has been shown to exercise effects on osteoclasts and periodontal ligament fibroblasts (Mimori et al. 2007)." (Clinical Periodontology and Implant Dentistry, 6th ed.)
• "One of vitamin C's principal roles is stimulating collagen synthesis by increasing the transcription of procollagen genes. For this reason, vitamin C induces periodontal ligament differentiation and osteoblast differentiation." (Newman & Carranza, 14th ed.)

4.3 Vitamin C Deficiency - Periodontal Manifestations

• "Severe vitamin C deficiency results in scurvy, and some of the clinical features of scurvy are hyperkeratosis, petechiae, ecchymosis, xerostomia, impaired wound healing, and inflamed and bleeding gums." (Newman & Carranza, 14th ed.)
• "In the absence of frank scurvy, the effect of declining ascorbic acid levels on the gingiva can be difficult to detect clinically, and when it is detected, it usually has characteristics that are similar to plaque-induced gingivitis." (Newman & Carranza, 14th ed.)
• "Severe vitamin C deficiency is considered a systemic risk factor for periodontitis, as it compromises antioxidant micronutrient defenses to oxidative stress and adversely influences collagen synthesis, resulting in weakened capillary blood vessel walls and enhanced gingival bleeding." (Burket's Oral Medicine, 13th ed.)
• Gingival involvement in scurvy: "swelling, friability, bleeding, secondary infection, and loosening of teeth. Implementation of a diet rich in vitamin C and administration of 1 g/d of vitamin C supplements provides rapid resolution." (Burket's Oral Medicine, 13th ed.)

4.4 2017 EFP/ORCA Workshop Recommendation

• "The 2017 EFP/ORCA Workshop concluded that dietary counseling on vitamin C and vitamin D intakes should be part of the information provided to our patients and caregivers." (Newman & Carranza, 14th ed.)

---

SECTION 5: VITAMIN E (TOCOPHEROL) - DETAILED ANALYSIS

5.1 Mechanism of Action

• "Vitamin E serves as an antioxidant to limit free-radical reactions and to protect cells from lipid peroxidation. Cell membranes, which are high in polyunsaturated lipids, are the major site of damage in patients with vitamin E deficiency." (Carranza's Clinical Periodontology, 10th ed.; Newman & Carranza, 14th ed.)
• "Vitamin E is an antioxidant that reduces free oxygen radicals - toxic substances that can cause DNA mutations, peroxidation of lipid membranes, and cell death. Free radicals are involved in a host of diseases affecting multiple organ systems, and antioxidant therapy may be useful in disease prevention, although the use of antioxidant supplementation remains controversial in the medical literature." (Periodontics Medicine Surgery Implants)
• "Evidence suggests that vitamin E acts as an antioxidant and plays an important role in maintaining the stability of cell membranes and protecting blood cells against hemolysis. The possible role is based upon its ability to interfere with the production of prostaglandins." (Essentials of Clinical Periodontology and Periodontics)

5.2 Periodontal Relevance

• "No relationship has been demonstrated between deficiencies in vitamin E and oral disease, but systemic vitamin E appears to accelerate gingival wound healing in the rat." (Carranza's 10th ed.; Newman 14th ed.)
• "There is a paucity of scientific data regarding the relation between vitamin E and the periodontium." (Periodontics Medicine Surgery Implants)

5.3 Vitamin E in Treatment of Osteoradionecrosis

• "The administration of the combination of pentoxifylline with vitamin E as antioxidant therapy currently shows the greatest promise for revascularization and treatment of osteoradionecrosis sites." (Newman & Carranza, 14th ed., Chapter on Medically Compromised Patients)

---

SECTION 6: NUTRITIONAL ANTIOXIDANTS - SYSTEMIC PERSPECTIVE

6.1 General Principles

• "Vitamins are defined as essential organic compounds that are catalysts for the body's metabolic reactions; they also function as electron donors, antioxidants, and transcription effectors. The bioavailability of those vitamins is regulated or influenced by other physiological factors, including the efficiency of gastrointestinal absorption and digestion." (Newman & Carranza, 14th ed.)
• "The role of nutrition in periodontal disease may be related to the effect of nutrition on inflammation. A 2009 review of the literature evaluating the effect of nutritional factors on inflammation demonstrated that subtle shifts in nutritional status are associated with the prevalence of periodontitis."
• "Data suggest that diets that contain foods rich in antioxidants are beneficial, whereas foods that contain high levels of refined carbohydrates are detrimental to the inflammatory process." (Newman & Carranza, 14th ed.)

6.2 Nutritional Deficiencies - Established Principles (Periodontics Medicine Surgery Implants)

1. "Animal studies have demonstrated inconclusively that when a large number of nutrients are either withheld from the diet or ingested in excessive amounts, a deleterious effect may be seen."
2. "Nutritional imbalance in humans does not cause periodontal disease without the presence of local factors. Deficiencies in nutrition appear to modify the severity and extent of periodontal disease by altering the host immunoinflammatory response and the potential for repair of the affected tissues."
3. "To date, intervention studies are lacking. Well-controlled nutritional studies in human subjects will be essential and helpful for definitive and valid assessment."
4. "Some nutritional deficiencies (e.g., calcium, vitamin C) have shown a weak to moderate association with the risk for periodontitis."
5. "Prevention or reversal of this disease by short-term nutritional therapy has not been demonstrated. Thus the fundamental basis for patient counseling relative to diet, nutrition, and periodontal disease rests with instructing the patient to ingest a nutritionally adequate diet in the long term."

6.3 Evidence from Interventional Studies

• "Early evidence from interventional studies (Campan et al. 1997; Staudte et al. 2005; Jenzsch et al. 2009; Chapple et al. 2012) suggests that adjunctive nutritional supplementation may result in improved periodontal therapy outcomes. Additional research from randomized placebo-controlled trials is needed to further document these effects." (Clinical Periodontology and Implant Dentistry, 6th ed.)
• "Epidemiologic studies reveal that periodontitis is associated with low serum/plasma micronutrient levels (Van der Velden et al. 2011)." (Clinical Periodontology and Implant Dentistry, 6th ed.)

---

SECTION 7: ANTIOXIDANT ACTIVITY OF LOCAL DELIVERY AGENTS AND ANTIMICROBIALS

7.1 Essential Oils

• Essential oil mouth rinse (eucalyptol 0.092%, menthol 0.042%, methyl salicylate 0.060%, thymol 0.064%): "Multiple mechanisms of action have been proposed, such as cell wall disruption, inhibition of bacterial enzymes, extraction of endotoxins derived from LPS of Gram-negative bacteria, and anti-inflammatory action based on antioxidant activity (Firatli et al. 1994; Sekino & Ramberg 2005)." (Clinical Periodontology and Implant Dentistry, 6th ed.)

7.2 Propolis

• "Propolis in an antioxidant-base formula" has been reported as one of the more recently investigated potential locally delivered treatments for periodontitis. (Newman & Carranza, 14th ed.)

7.3 Tetracyclines (Scavenging of Reactive Oxygen Metabolites)

• "Anti-inflammatory properties include the ability of tetracyclines to suppress polymorphonuclear leukocyte (PMNL) activity, in particular, the scavenging action of reactive oxygen metabolites. Alternatively, the drugs may block eicosanoid synthesis (PGE2) by inhibiting phospholipase A2 activity." (Essentials of Clinical Periodontology and Periodontics)

7.4 Photodynamic Therapy (PDT)

• In PDT, "reactive oxygen species [are generated], thus killing the harmful bacteria."
• Fig. 54.5 in Essentials of Clinical Periodontology and Periodontics shows: "Mechanism of action of photodynamic therapy. Abbreviations: H2O2, hydrogen peroxide; O2, oxygen; ROS, reactive oxygen species." (Essentials of Clinical Periodontology and Periodontics)

---

SECTION 8: ANTIOXIDANTS IN SPECIFIC PERIODONTAL CONDITIONS

Table 3: Antioxidant Relevance in Specific Conditions

---

SECTION 9: COMPARISON OF VIEWPOINTS ACROSS REFERENCES

Table 4: Comparison of Key Statements Across References

---

SECTION 10: KEYWORDS SUMMARY FOR EXAMINER

• Reactive oxygen species (ROS) - hydroxyl radical, superoxide, peroxide
• ROS scavengers / free radical scavenger
• Oxidative stress - common link between obesity, diabetes, and periodontitis
• Antioxidant capacity - decreased in individuals with periodontitis
• Lipid peroxidation - mechanism of cell membrane damage
• DNA damage - caused by reactive oxygen radicals (especially in smoking)
• Metallothionein - free radical scavenger increased in gingival tissue of smokers
• Vitamin C (ascorbic acid) - "powerful antioxidant radical scavenger"; distributed in PMNs, platelets, endothelial cells
• Vitamin E (tocopherol) - antioxidant; limits free-radical reactions; protects cell membranes; accelerates gingival wound healing in rat
• Glutathione, carotenoids, polyphenols - antioxidant micronutrients associated with periodontal status
• Chapple & Matthews 2007 - "role of reactive oxygen and antioxidant species in periodontal tissue destruction" (Periodontology 2000)
• AGE-RAGE pathway - links hyperglycemia to oxidative stress in periodontitis
• Pentoxifylline + Vitamin E - antioxidant therapy for osteoradionecrosis
• Essential oils - anti-inflammatory action via antioxidant activity
• Tetracyclines - scavenging of reactive oxygen metabolites
• Propolis - in antioxidant-base formula as local delivery agent
• Photodynamic therapy - generates ROS (H2O2, O2) to kill bacteria
• 2017 EFP/ORCA Workshop - dietary counseling on vitamin C and vitamin D recommended
• Malnutrition - marked tissue depletion of key antioxidant nutrients; predisposes to necrotizing periodontal disease

---

SECTION 11: IMPORTANT RECENT TERMINOLOGY / TERMINOLOGY NOTES

1. The reference Chapple, I.L. & Matthews, J.B. (2007) is cited verbatim as: "The role of reactive oxygen and antioxidant species in periodontal tissue destruction" in Clinical Periodontology and Implant Dentistry 6th ed. - this is the landmark reference for this topic.
2. Newman & Carranza 14th ed. uses "obesity and oxidative stress in patients with different periodontal status" (Atabay VE, Lutfioglu M, Avci B, et al. - J Periodontal Res. 2017;52:51-60) as a cited reference under systemic conditions.
3. The term "antioxidant micronutrient defenses to oxidative stress" (Burket's 13th ed.) specifically contextualizes vitamin C deficiency as compromising the host defense antioxidant system.
4. The 14th ed. of Newman distinguishes omega-3 fatty acids (immunomodulatory) from antioxidants (ROS scavengers) - these are separate categories with different mechanisms.
5. The 6th ed. of Clinical Periodontology and Implant Dentistry separates micronutrients into antioxidant (vitamin E, carotenoids, polyphenols, glutathione) and non-antioxidant (vitamin B, omega-3 polyunsaturated fatty acids) - this classification is examinable.

---

SECTION 12: POINTS NOT PRESENT IN UPLOADED REFERENCES

• Specific TRAP (Total Radical-Trapping Antioxidant Parameter) or FRAP (Ferric Reducing Ability of Plasma) assay values
• Salivary antioxidant capacity / Total Antioxidant Status (TAS) measurement protocols
• Specific data on lycopene, resveratrol, or N-acetyl cysteine in periodontal therapy
• NADPH oxidase mechanism in detail
• 8-OHdG or isoprostane as biomarkers in periodontal context
• Malondialdehyde levels in GCF

---

• Short answer (5-10 marks): Focus on Sections 1-3 (ROS definition, oxidative stress in periodontitis, Table 1 on antioxidant micronutrients)
• Long answer / essay (15-20 marks): Cover all 12 sections; the examiner will expect the Chapple & Matthews 2007 citation, the AGE-RAGE-oxidative stress pathway flowchart (Section 2.3), the 4-way classification in Table 4, and the pentoxifylline + Vitamin E use in osteoradionecrosis
• Viva preparation: The most commonly tested fact is that "no nutritional deficiency by itself causes gingivitis or periodontitis" combined with "diets rich in antioxidants are beneficial" - the examiner expects both statements together as a nuanced answer
• Section 12 (Not in references) protects against fabrication in your exam answer - if you cannot cite a reference, state that "the specific data on [topic] requires further evidence"

---

LANDMARK & IMPORTANT STUDY ARTICLE NOTES

Antioxidants in Periodontics - Postgraduate Examination Reference

---

HOW TO USE THESE NOTES

• Articles are organized thematically by topic, then chronologically within each theme
• Evidence Tier follows the hierarchy: Systematic Review/Meta-Analysis > RCT > Cross-sectional/Case-control > Review
• Importance Rating reflects examiner relevance for postgraduate periodontology
• Key Contribution summarizes what the paper proved or proposed

---

THEME 1: FOUNDATIONAL / CONCEPTUAL PAPERS - ROS & ANTIOXIDANTS IN PERIODONTITIS

---

📄 PAPER 1 - THE ORIGINAL LANDMARK REVIEW

• FIRST major periodontal paper to systematically review the role of free radical-induced tissue damage and antioxidant defence mechanisms in inflammatory diseases as they relate to periodontitis
• Established that "there is a clearly defined and substantial role for free radicals or reactive oxygen species (ROS) in periodontitis"
• Introduced the concept of the transcription factor NF-kappa B in periodontal disease - proposed that NF-κB activation by cytokines mediates periodontal tissue damage
• Identified key cytokines studied in periodontitis: TNF-α, IL-1, IL-6, IL-8, and β-interferon as NF-κB-linked mediators
• Highlighted the antioxidant thiols - cysteine and reduced glutathione (GSH) - as critical links between cellular ROS production and cytokine-induced inflammation
• First to hypothesize that NF-κB antagonists may offer important therapeutic benefits in periodontitis
• Called for significantly more periodontal research in this area - regarded as the paper that launched this entire field
• Examiner keyword: "first paper to draw parallels between ROS in systemic inflammatory diseases and periodontitis"

---

📄 PAPER 2 - FOUNDATIONAL ASSAY DEVELOPMENT

• Developed and validated the Enhanced Chemiluminescence (ECL) assay for measuring Total Antioxidant Capacity (TAOC) in serum, saliva and GCF - this became the gold standard method for subsequent decades of periodontal antioxidant research
• Demonstrated calibration lines were linear (R ≥ 0.99; P < 0.0001) with within-batch coefficient of variations < 5%
• First study to measure and compare TAOC in all three clinical compartments simultaneously (serum, saliva, GCF)
• Critical finding: Salivary total antioxidant concentrations were significantly lower in the periodontitis group [175 (53) µmol/L] compared to non-periodontitis group [254 (110) µmol/L; P < 0.01]
• Identified a characteristic antioxidant response in saliva and GCF not seen in serum - suggesting local oral-specific antioxidant defence mechanisms exist
• The Trolox equivalent (µmol/L Trolox) became the unit of measurement for subsequent TAOC studies
• Introduced the concept that GCF antioxidant capacity may both result from and predispose to ROS-mediated damage
• Examiner keyword: "ECL assay"; "Trolox equivalent"; "GCF-specific antioxidant response not seen in serum"

---

📄 PAPER 3 - LANDMARK - GCF GLUTATHIONE CHARACTERIZATION

• First paper to specifically quantify glutathione (GSH) concentrations in GCF of periodontally healthy vs. chronic periodontitis patients using HPLC
• Critical finding: Control GCF contained high mean concentrations of GSH (1899.8 ± 494.4 µM) - whereas GCF from periodontitis patients had significantly lower GSH (1183.1 ± 580.3 µM)
• GSSG (oxidised glutathione) also significantly reduced in periodontitis GCF (150.1 ± 44.9 µM vs. 256.8 ± 152.4 µM in controls)
• Plasma and GCF TAOC both lower in periodontitis patients vs. controls
• The stepped antioxidant response unique to GCF (inhibited by N-ethylmaleimide) was identified as the GSH-dependent component
• Proposed the analogy with extracellular lung GSH - suggesting GCF represents an important antioxidant/anti-inflammatory defence strategy common to exposed epithelial surfaces
• Established glutathione as a dominant contributor to GCF's local antioxidant capacity
• Examiner keyword: "master antioxidant"; "GSH dominant in GCF"; "HPLC quantification"; "exposed epithelial surface analogy"

---

📄 PAPER 4 - LOCAL vs. SYSTEMIC TAOC - PIVOTAL CROSS-SECTIONAL STUDY

• Definitive characterization of GCF antioxidant capacity as both qualitatively and quantitatively distinct from saliva, plasma and serum
• Studied 20 non-smoking chronic periodontitis patients vs. 20 age/sex-matched non-smoking controls
• Critical finding: GCF antioxidant concentration significantly lower (p<0.001) in periodontitis vs. healthy subjects
• Plasma TAOC also lower in periodontitis (p<0.05) but the difference was less dramatic than GCF
• Healthy subjects' GCF antioxidant concentration was significantly greater than paired serum or plasma (p<0.001) - demonstrating that the periodontal site is normally maintained in a hyperoxidant-defended state
• Male bias found in all clinical samples except GCF
• Raised the critical question: "Whether changes in the GCF compartment in periodontitis reflect predisposition to or the results of ROS-mediated damage" - the cause vs. effect debate
• Examiner keywords: "local compartment uniquely defended"; "predisposition vs. consequence debate"; "non-smoking cohort"

---

📄 PAPER 5 - CAUSE OR EFFECT? - LONGITUDINAL RESOLUTION

• The definitive paper answering whether compromised GCF TAOC in periodontitis is a cause or effect - the most cited paper in this specific debate
• Two-study longitudinal design: Study 1 (n=17, mild disease sites), Study 2 (n=18, deep sites)
• Key baseline finding: No differences in plasma TAOC between periodontitis patients and controls (507±92 vs. 520±100 µMTeq; p=0.57); but GCF TAOC significantly lower in CP (680±371 vs. 1129±722 µMTeq; p<0.0001)
• Most important outcome: Successful periodontal therapy (non-surgical) did not alter plasma TAOC (p=0.56), but GCF TAOC increased significantly (by 449±722 µMTeq, p<0.001) to control subject levels
• Conclusion: "Local total antioxidant capacity in CP appears to reflect increased oxygen radical activity during periodontal inflammation and CAN BE RESTORED to control subject levels by successful non-surgical therapy"
• Implication: Compromised GCF TAOC is a consequence (effect) of the inflammatory process, not a pre-existing predisposition - meaning treating periodontitis restores antioxidant balance
• This paper established non-surgical therapy as the first-line antioxidant intervention
• Examiner keywords: "cause vs. effect resolved in favour of effect"; "TAOC restored by NSPT"; "local vs. systemic dissociation"

---

THEME 2: SYSTEMATIC REVIEWS AND META-ANALYSES - OXIDATIVE STRESS BIOMARKERS

---

📄 PAPER 6 - FIRST MAJOR META-ANALYSIS OF SYSTEMIC OS BIOMARKERS

• First formal meta-analysis quantifying the systemic oxidative stress burden in chronic periodontitis
• Included 31 eligible articles; 16 with available data for meta-analysis
• Critical quantitative findings (Standardized Mean Differences):

• Established MDA, nitric oxide, and TAC as the most reliable systemic biomarkers of oxidative stress in periodontitis
• SOD was NOT significantly different - important negative finding for exam
• Confirmed that periodontitis is significantly associated with systemic oxidative stress, strengthening the periodontal-systemic disease link
• Examiner keywords: "MDA, NO elevated; TAC decreased systemically"; "SOD not significant"; "first quantitative meta-analysis of systemic biomarkers"

---

📄 PAPER 7 - META-ANALYSIS OF LOCAL (SALIVA AND GCF) BIOMARKERS

• Most comprehensive local-site meta-analysis - 32 studies included; searched 3 databases
• Salivary findings (significant):
  • TAC: significantly DECREASED in CP
  • MDA: significantly INCREASED in CP
  • Nitric oxide: significantly INCREASED in CP
  • Total Oxidant Status (TOS): significantly INCREASED in CP
  • 8-hydroxy-deoxyguanosine (8-OHdG): significantly INCREASED in CP - first meta-analytic confirmation of DNA oxidative damage
• GCF findings (significant): MDA significantly elevated in CP GCF
• Non-significant findings (important for exam): Salivary SOD, salivary glutathione peroxidase, GCF TOS
• Concluded: direct link between CP and OS-related biomarkers at the local site, confirming oxidative stress is integral to CP onset and development
• Published in J Clin Periodontol - the highest impact periodontal journal
• Examiner keywords: "8-OHdG in saliva"; "TOS vs. TAC imbalance"; "local site biomarkers"; "SOD and GSH-Px not significant locally"

---

📄 PAPER 8 - META-ANALYSIS OF TOS/TAC IN MULTIPLE BIOFLUIDS

• Most comprehensive recent meta-analysis specifically on TOS and TAC as paired markers across multiple biological fluids
• Screened 1,812 articles; 42 met inclusion criteria; 24 included in quantitative analysis
• Key findings by fluid compartment:

• Post-therapy finding: TAC did not significantly increase after periodontal therapy (p=0.130) - provides nuance to Chapple 2007's finding and suggests incomplete restoration of systemic antioxidant capacity
• Clinical relevance: OS biomarker levels can be used to assess periodontal disease and therapeutic efficacy
• Examiner keywords: "salivary TAC not significant after therapy"; "GCF TOS elevated"; "multiple fluid compartment analysis"

---

📄 PAPER 9 - META-ANALYSIS: CP + TYPE 2 DIABETES

• Addressed the specific question: Are OS biomarkers different in CP + T2DM vs. CP alone?
• 19 studies met inclusion criteria
• Critical and surprising finding: No significant differences in SOD, TAC, MDA, or GSH between DMCP vs. CP groups
• Exception: Catalase (CAT) was significantly REDUCED in DMCP vs. CP alone - the only biomarker showing diabetes-specific difference
• Implication: Catalase may be the key enzyme linking T2DM-enhanced oxidative stress to worse periodontal outcomes
• Highlights that while both conditions involve oxidative stress, their biomarker signatures overlap considerably
• Examiner keywords: "catalase uniquely reduced in diabetic periodontitis"; "SOD/MDA/GSH not significantly different"; "T2DM-specific biomarker signature"

---

THEME 3: ANTIOXIDANT THERAPEUTIC STUDIES (RCTs AND SYSTEMATIC REVIEWS)

---

📄 PAPER 10 - LANDMARK RCT - GRAPEFRUIT/VITAMIN C

• One of the first RCTs to test dietary vitamin C supplementation in periodontitis - also cited in Lindhe's Clinical Periodontology as a key interventional study (Campan et al. 1997; Staudte et al. 2005 are cited together)
• Studied 58 patients with chronic periodontitis (test: 21 non-smokers + 17 smokers; diseased control: 11 non-smokers + 9 smokers) plus 22 healthy controls
• Key finding at baseline: Plasma vitamin C levels significantly reduced in periodontitis patients vs. healthy controls - confirming the antioxidant micronutrient deficit hypothesis
• Smokers had lower vitamin C (mean 0.39 ± 0.17 mg/dL) than non-smokers (0.56 ± 0.29 mg/dL) even within periodontitis group
• After grapefruit consumption: Plasma vitamin C significantly rose and Sulcus Bleeding Index (SBI) significantly improved in test group (non-smokers: from 1.68±0.6 to 1.05±0.6; p<0.001)
• Plaque Index and Pocket Depth were NOT significantly affected by vitamin C supplementation alone
• Limitation acknowledged: Longer-term studies needed; unclear whether structural periodontal outcomes improve
• Examiner keywords: "Staudte 2005 - dietary Vit C RCT"; "SBI improved, PPD unchanged"; "smokers have lowest vitamin C"; "natural food source supplementation"

---

📄 PAPER 11 - SYSTEMATIC REVIEW - VITAMIN C SUPPLEMENTATION IN PERIODONTITIS

• The authoritative systematic review on vitamin C supplementation as adjunctive therapy to NSPT
• Searched PubMed, EMBASE, Cochrane Library, Web of Science; included RCTs from 1990-2020; 6 studies met criteria
• Critical conclusion: "Administration of vitamin C as an adjunct to NSPT did not result in clinically significant improvements in pocket probing depths at 3 months in periodontitis patients"
• Vitamin C supplementation DID help improve bleeding indices in gingivitis - important distinction
• Key distinction: Benefits seen for gingivitis (bleeding) but NOT for periodontitis (structural outcomes - PPD, CAL)
• "With the limited evidence available, no recommendation can be made for supplementation of vitamin C in conjunction with initial periodontal therapy for subjects with periodontitis to improve primary treatment outcome measures"
• Limitation: Only 6 studies; heterogeneity in protocols; all short-term (3 months)
• Examiner keywords: "Vit C - no CAL gain"; "bleeding improves in gingivitis only"; "Level of Evidence insufficient for recommendation"; "antioxidant potential useful theoretically but not proven clinically for structural outcomes"

---

📄 PAPER 12 - SYSTEMATIC REVIEW AND META-ANALYSIS - CoQ10 IN PERIODONTITIS

• Most comprehensive quantitative analysis of CoQ10 (Coenzyme Q10) in periodontitis - 11 trials included in meta-analysis
• All primary clinical outcomes significantly improved with CoQ10:

• Route matters: Intra-pocket CoQ10 administration had stronger reduction effect than topical administration
• High risk of bias in many included studies limits conclusions
• Examiner keywords: "CoQ10 gel"; "intra-pocket > topical"; "all 5 clinical parameters improved"; "high heterogeneity (I²=72-89%)"

---

📄 PAPER 13 - SYSTEMATIC REVIEW - CoQ10 PROTOCOLS (MORE RECENT)

• Addressed heterogeneity in CoQ10 study protocols - an important issue raised after Paper 12 above
• 17 RCTs included: 12 used local CoQ10 administration (once or several times over ≤15 days); 5 used systemic CoQ10 (twice or three times daily for 6 weeks to 4 months)
• Critical problem: Reporting quality was LOW, including missing information about CoQ10 doses
• Risk of bias was high or unclear in most studies
• About half the studies reported significant group differences for PPD
• Conclusion: "Until now, no definitive statement on the effectiveness of CoQ10 in non-surgical periodontitis therapy is possible"
• Published specific protocol recommendations for future RCTs - standardization of dose, route, duration needed
• Examiner keywords: "protocol heterogeneity"; "dose not reported"; "half show PPD improvement"; "no definitive conclusion possible"

---

📄 PAPER 14 - RCT - MULTINUTRIENT ANTIOXIDANT SUPPLEMENT + SRP (STAGE III/IV)

• First high-quality double-blind RCT of a comprehensive multinutrient antioxidant supplement (containing vitamin C, vitamin E, zinc, selenium, alpha-lipoic acid, cranberry extract, grapeseed extract, and CoQ10) adjunctive to SRP for Stage III/IV periodontitis (2017 classification)
• 42 patients; 2-month supplementation period
• Statistically significant benefits of multinutrient supplementation:
  • Probing pocket depth: -0.75±0.42 mm (supplement) vs. -0.51±0.30 mm (placebo); p=0.040
  • Bleeding on probing: -21.9±16.1% (supplement) vs. -12.5±9.8% (placebo); p=0.046
• All other parameters (CAL, recession, API, PESA) showed non-significant but higher improvement in supplement group
• Limitation: Clinical relevance of the statistically significant differences in PPD and BOP needs further exploration; small sample; 2-month follow-up
• Uses 2017 EFP/AAP staging and grading classification (Stage III and IV) - making it relevant to current clinical practice
• Examiner keywords: "multicomponent antioxidant adjunct"; "Stage III/IV periodontitis"; "PPD and BOP significantly improved"; "CoQ10 + Vit C + Vit E + alpha-lipoic acid combination"; "clinical significance uncertain"

---

📄 PAPER 15 - META-ANALYSIS - ANTIOXIDANTS IN T2DM-PERIODONTITIS PATIENTS

• The most recent and most clinically relevant meta-analysis - specific to T2DM-periodontitis patients, covering antioxidants tested: melatonin, propolis, lycopene, ginger, vitamin C, omega-3 fatty acids, grape seed extract
• Key quantitative findings by antioxidant:

• Melatonin and propolis emerged as the most effective antioxidant adjuncts in the diabetic periodontitis subgroup - both improving CAL, PD, and glycemic control (HbA1c)
• Evidence certainty: Moderate for CAL/HbA1c; Low for PD/GI
• Examiner keywords: "melatonin and propolis best performers in T2DM"; "glycemic benefit - HbA1c reduction"; "vitamin C and omega-3 minimal impact"; "2025 meta-analysis"

---

THEME 4: MAJOR REVIEWS - MECHANISM AND THERAPEUTICS

---

📄 PAPER 16 - MAJOR REVIEW - "TREAT IT AS OXIDATIVE STRESS DISEASE"

• Published in Periodontology 2000 - the most authoritative periodontal review journal - making this THE most important review to cite in a PG examination on this topic
• Paradigm-shifting argument: Periodontitis should be conceptualized and TREATED as a disease of oxidative stress, not just infection
• Proposed that once periodontitis is triggered by bacteria, PMN-derived ROS upregulation may be one of the MOST IMPORTANT mechanisms in disease establishment and progression
• Reviews innate and epigenetic factors (diabetes, smoking) that lead to oxidative stress environment
• Key therapeutic agents reviewed with anti-oxidant/anti-inflammatory mechanisms:
  • Resveratrol - detailed evidence reviewed; suppresses NF-κB; SIRT1 pathway
  • Green tea catechins (EGCG)
  • N-acetyl cysteine
  • Omega-3 fatty acids
  • Statins (indirect antioxidant via NF-κB suppression)
• Reviewed evidence for novel approaches: antioxidant delivery systems, nanoparticles, local sustained-release antioxidants
• Examiner keywords: "periodontitis as disease of oxidative stress"; "PMN ROS central hypothesis"; "resveratrol and SIRT1 pathway"; "Periodontology 2000, 2020"

---

📄 PAPER 17 - REVIEW - GLUTATHIONE AS MASTER ANTIOXIDANT

• Comprehensive review designating glutathione (GSH) as the "master antioxidant" in periodontal context - a key examiner term
• Summarizes evidence that "periodontitis patients have reduced total AO capacity in whole saliva, and lower concentrations of reduced glutathione (GSH) in serum and GCF"
• Confirms that "periodontal therapy restores the redox balance" - consistent with Chapple 2007
• Reviews GSH synthesis, recycling (glutathione peroxidase/reductase cycle), and its role as the dominant thiol-based antioxidant in GCF
• "The highest concentrations of GSH found extracellularly in the body are in GCF and lung lining fluid" - both are exposed epithelial surfaces
• Reviews potential therapeutic use of GSH supplementation, GSH precursors (N-acetyl cysteine), and GSH-enhancing compounds
• "Multi-centered RCTs are needed to evaluate adjunctive use of glutathione in management of periodontitis"
• Examiner keywords: "master antioxidant"; "redox balance restored by therapy"; "GSH highest extracellularly in GCF and lung fluid"; "N-acetyl cysteine as GSH precursor"

---

📄 PAPER 18 - REVIEW - RESVERATROL IN PERIODONTITIS

• First dedicated review of resveratrol and its glycosylated derivative THSG (2,3,5,4'-tetrahydroxystilbene-2-O-β-glucoside) in periodontitis
• Resveratrol is a polyphenol from Polygonum multiflorum with anti-inflammatory and antioxidant properties
• Mechanisms reviewed: Suppresses P. gingivalis-induced inflammatory responses in human gingival fibroblasts; tested in ligature-induced periodontitis animal models
• Signal transduction pathways: NF-κB inhibition; SIRT1 activation; downregulation of IL-6, IL-8, TNF-α, MMP production
• THSG showed anti-inflammatory properties comparable to or exceeding resveratrol in some models
• Examiner keywords: "resveratrol polyphenol"; "THSG glycosylated derivative"; "SIRT1 activation"; "P. gingivalis-induced inflammation in gingival fibroblasts"; "ligature model"

---

📄 PAPER 19 - SYSTEMATIC REVIEW - VITAMINS AND PERIODONTAL HEALTH

• Most comprehensive systematic review covering ALL vitamins in periodontal disease - both human and animal evidence
• Conclusions by vitamin category:
  • Antioxidant vitamins (C, E, carotenoids/beta-carotene): "Quite substantial information in favor of antioxidant vitamins, mainly vitamin C which is the most studied"
  • Bone metabolism vitamins (D, K): "Vitamin D seems to have the most relevant role" in bone-mediated periodontal changes
  • Overall: "Vitamins with antioxidant capacity and effects on immune system seem to be useful for prevention or improvement of periodontal disease, as well as those implicated in bone metabolism"
• Highlights vitamin C as the most evidence-supported antioxidant vitamin for periodontal health
• Examiner keywords: "Vitamin C - most studied antioxidant vitamin"; "Vitamin D - bone metabolism role"; "antioxidant + immune function vitamins most relevant"

---

📄 PAPER 20 - MENDELIAN RANDOMIZATION - CAUSAL EVIDENCE FOR ANTIOXIDANTS

• First Mendelian Randomization (MR) study testing causal relationships between circulating antioxidants and periodontitis - MR provides near-experimental causal evidence from observational data
• Antioxidants tested: copper, selenium, zinc, ascorbate (vitamin C), β-carotene, lycopene, retinol, vitamin E
• Critical causal finding: Only RETINOL (Vitamin A) showed a significant negative causal relationship with periodontitis risk
  • GLIDE database: OR=0.41 (95% CI 0.18-0.95; p=0.038)
  • FinnGen database: OR=0.15 (95% CI 0.04-0.54; p=0.004)
  • Pooled OR: 0.30 (95% CI 0.15-0.61; p=0.001; I²=40.3%)
• No other antioxidant showed significant causal association with periodontitis - including vitamin C, vitamin E, lycopene
• No significant associations for any antioxidant with dental caries
• This suggests that vitamin A/retinol may have a unique causal protective role against periodontitis, independent of other antioxidants
• Examiner keywords: "Mendelian randomization - causal evidence"; "retinol uniquely protective causally"; "vitamin C and E not causally protective in MR"; "GLIDE + FinnGen databases"

---

SUMMARY TABLE: ALL PAPERS AT A GLANCE

---

EXAMINER'S EXPECTED KNOWLEDGE TRAJECTORY

CHAPPLE 1997a (conceptual foundation)
        |
        v
CHAPPLE 1997b (ECL assay - how we measure it)
        |
        v
CHAPPLE 2002 (GSH as dominant GCF AO)
        |
        v
BROCK et al. 2004 (local vs. systemic - GCF uniquely defended)
        |
        v
CHAPPLE 2007 (cause vs. effect RESOLVED - NSPT restores AO)
        |
        v
META-ANALYSES (Liu 2014 + Chen 2019 + Mohideen 2023)
(quantified: TAC decreased, MDA/TOS/8-OHdG increased)
        |
        v
THERAPEUTIC TRIALS
(Staudte 2005 / Fageeh 2021: Vit C limited; CoQ10 - promising but
heterogeneous; Laky 2024: multinutrient - PPD/BOP improved;
Abdulla 2025: Melatonin+Propolis best in T2DM)
        |
        v
FUTURE DIRECTION
(Sczepanik 2020: Treat as oxidative disease - resveratrol, antioxidant
delivery; Gao 2024 MR: only retinol causally protective)

---

• Chapple 1997a (PMID 9178107) - foundational concept paper; first to link ROS and NF-κB to periodontitis
• Chapple 1997b (PMID 9247675) - ECL assay; first TAOC measurement in GCF
• Chapple 2002 (PMID 12456773) - glutathione as the dominant GCF antioxidant
• Brock et al. 2004 (PMID 15191586) - GCF antioxidant capacity uniquely greater than serum
• Chapple et al. 2007 (PMID 17214737) - THE cause-or-effect paper; NSPT restores GCF TAOC
• Chen et al. 2019 (PMID 30989678) - definitive SR/MA for local (saliva/GCF) biomarkers
• Fageeh et al. 2021 (PMID 33397446) - vitamin C supplementation does NOT improve PPD/CAL
• Sczepanik et al. 2020 (PMID 32844417) - Periodontology 2000 flagship review; "treat it as oxidative stress disease"
• Laky et al. 2024 (PMID 37439597) - most recent RCT; multinutrient AO improves PPD and BOP in Stage III/IV